Review : Hydroxychloroquine and chloroquine for treatment of SARS-CoV-2 (COVID-19)
-
Pastick, Katelyn A. (Department of Medicine. University of Minnesota)
;
Okafor, Elizabeth C. (Department of Medicine. University of Minnesota) ;
Wang, Fan (Department of Experimental and Clinical Pharmacology. University of Minnesota) ;
Lofgren, Sarah M. (Department of Medicine. University of Minnesota) ;
Skipper, Caleb P. (Department of Medicine. University of Minnesota) ;
Nicol, Melanie R. (Department of Experimental and Clinical Pharmacology. University of Minnesota) ;
Pullen, Matthew F. (Department of Medicine. University of Minnesota) ;
Rajasingham, Radha (Department of Medicine. University of Minnesota) ;
McDonald, Emily G. (Clinical Practice Assessment Unit. Department of Medicine. McGill University Health Centre) ;
Lee, Todd C. (Clinical Practice Assessment Unit. Department of Medicine. McGill University Health Centre) ;
Schwartz, Ilan S. (Division of Infectious Diseases. Department of Medicine. Faculty of Medicine and Dentistry. University of Alberta) ;
Kelly, Lauren E. (Department of Pediatrics and Child Health. Department of Pharmacology. University of Manitoba) ;
Lother, Sylvain A. (Department of Medicine. Sections of Critical Care and Infectious Diseases. University of Manitoba) ;
Mitjà, Oriol (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Letang, Emili (Barcelona Institute for Global Health (ISGlobal)) ;
Abassi, Mahsa (Department of Medicine. University of Minnesota) ;
Boulware, David R. (Department of Medicine. University of Minnesota)